HANNAH VAN DER WATER: Open Payments
NPI 1841704798 · SUPERIOR, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $300 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 1 | $130 |
| Gilead Sciences, Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Lilly USA, LLC | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Seqirus USA Inc | 1 | $27 |
| ViiV Healthcare Company | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $23 |
| PFIZER INC. | 1 | $22 |
Products named: Cleerly Ischemia, NEXIUM, SHINGRIX, KISUNLA, Flucelvax, APRETUDE, The Cologuard Plus Collection Kit, APTIMA.
Industry payments across CO — which companies pay providers there.
